SCHEMBL29806269

SCHEMBL29806269

N=C(NO)c1cnccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.48
▸ NAPRT Q6XQN6 1/20 0.48
▸ HCAR2 Q8TDS4 1/20 0.48
▸ BAZ2B Q9UIF8 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MC4R P32245 1/20 0.47
▸ ADRA1A P35348 1/20 0.47
▸ MC3R P41968 1/20 0.47
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MCL1 Q07820 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ PABPC1 P11940 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL640866 1.00 KDM4E (0.48) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL4904135 0.83 BAZ2B (0.52) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL12745729 0.78 KDM4E (0.44) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL1412848 0.74 KDM4E (0.59) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL14903392 0.73 — —
SCHEMBL1442775 0.73 — —
SCHEMBL1461124 0.72 KDM4E (0.47) KDM4ENAPRTHCAR2BAZ2BADORA3
Hydrochloric Acid SCHEMBL3134310 0.71 BAZ2B (0.59) KDM4ENAPRTHCAR2BAZ2BADORA3
SCHEMBL22859955 0.71 KDM4E (0.50) KDM4ENAPRTHCAR2BAZ2BADORA3
Hydrochloric Acid SCHEMBL7668906 0.71 BAZ2B (0.59) KDM4ENAPRTHCAR2BAZ2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003983-A1 1,2,4-OXADIAZOL-5-ONE DERIVATIVES FOR THE TREATMENT OF CANCER Basilea Pharmaceutica International AG (CH) 2022-06-01 — — EP disclosed
Send feedback